Pelvic organ prolapse repair is a specialised reconstructive surgical intervention within urogynecology and reconstructive pelvic surgery. The primary goal of the procedure is to correct structural defects in the pelvic floor—the muscular and connective tissue hammock that supports the bladder, uterus, vaginal apex, and rectum. When these supportive structures stretch, tear, or attenuate, organs shift downward, producing physical discomfort, voiding difficulty, or bowel evacuation problems. Repair techniques reconstruct these fascial planes and re-suspend apical structures to their natural anatomical anchoring points on the pelvic side walls or sacral ligaments.

Pelvic organ prolapse repair involves several distinct surgical phases performed under general or spinal anaesthesia. The patient is placed in the dorsal lithotomy position. For anterior repair (cystocele), a midline vaginal incision is made, freeing the overlying mucosa from the bladder base. The weakened endopelvic fascia is plicated (stitched together) using absorbable sutures to reduce the bladder hernia. For posterior repair (rectocele), a posterior mucosal incision exposes the rectovaginal septum, which is re-approximated to reinforce the wall between vagina and rectum. Perineorrhaphy may be performed to tighten the perineal body. For apical prolapse (uterine or vault descent), the apex is attached to high ligamentous structures using strong non-absorbable or long-delayed absorbable sutures. Techniques include uterosacral ligament suspension, sacrospinous ligament fixation, or abdominal/laparoscopic sacrocolpopexy, where polypropylene mesh connects the vaginal vault to the anterior longitudinal ligament of the sacrum. Cystoscopy is performed at the end of surgery to confirm ureteral patency and rule out bladder injury.

Surgical correction provides significant objective and subjective clinical benefits for individuals with advanced prolapse. Clinical evidence shows substantial improvement in quality-of-life scores, elimination of vaginal bulge symptoms, and correction of related mechanical voiding or defecation dysfunction (ACOG Practice Bulletin No. 214). Apical re-suspension and compartment repair successfully restore functional vaginal axis length, reduce pelvic pressure, and facilitate improved pelvic floor physical therapy outcomes.

Recovery following pelvic organ prolapse repair follows a structured multi-week trajectory. Initial hospital discharge occurs within 24 to 48 hours following a successful voiding trial and adequate pain control. Patients resume light walking immediately but must refrain from heavy lifting (greater than 10 pounds), strenuous exercise, constipation-induced straining, and vaginal penetration for 6 to 8 weeks to allow endopelvic tissue healing. Full tissue strength remodeling continues across 3 to 6 months post-surgery.

Pelvic organ prolapse repair treats symptomatic apical, anterior, and posterior pelvic support defects. Specific conditions addressed include cystocele (anterior compartment bulge of the bladder into the vagina), rectocele (posterior compartment bulge of the rectum into the vagina), enterocele (herniation of the small bowel into the upper vagina), and uterine or apical vault prolapse (descent of the uterus or post-hysterectomy vaginal cuff). It also addresses secondary mechanical symptoms such as urinary retention, incomplete bowel emptying, and physical discomfort during intimacy.

Pre-operative preparation begins weeks before surgery. Clinical evaluation includes physical exam, POP-Q scoring, urinalysis, urine culture, and urodynamic testing if urinary incontinence or occult voiding dysfunction is suspected. Postmenopausal patients may be prescribed topical vaginal estrogen for 4 to 6 weeks prior to surgery to improve tissue elasticity and surgical plane vascularity. Patients must discontinue antiplatelet or anticoagulant medications under medical supervision 5 to 7 days before the procedure. Bowel preparation with mild laxatives or clear liquids may be recommended the day prior. Fasting is required for 8 hours prior to anaesthesia. Pre-operative antibiotic prophylaxis is administered intravenously within 60 minutes of surgical incision.

Complications associated with pelvic organ prolapse repair vary by surgical approach and compartment. Minor risks include transient urinary tract infection, postoperative urinary retention requiring temporary catheterization, mild vaginal spotting, and localized pelvic ache. Moderate risks include pelvic hematoma, surgical site infection, voiding dysfunction, de novo urge or stress urinary incontinence, dyspareunia (painful intercourse), and recurrence of prolapse in the same or adjacent compartment. Major but rare risks include ureteral kinking or injury, bladder or rectal perforation, deep vein thrombosis, pulmonary embolism, and mesh erosion or exposure (if synthetic mesh is used in sacrocolpopexy). Mesh exposure may require revision surgery or partial removal.

The clinical path for pelvic organ prolapse repair begins with a structured diagnostic evaluation, including physical examination using the Pelvic Organ Prolapse Quantified (POP-Q) system. Patients undergo pre-operative health optimization, voiding studies, and discussion of surgical approaches. Surgery is performed under general or regional anaesthesia, lasting 1 to 3 hours depending on the complexity and number of anatomical compartments involved. Post-operative care involves a brief hospital stay of 24 to 48 hours, early ambulation, voiding trial, and structured physical restrictions for 6 to 8 weeks. Long-term follow-up spans 12 months to monitor anatomical durability, functional symptom improvement, and pelvic floor muscle recovery.